A woman who was the first patient in Europe to take part in a trial testing a personalised cancer vaccine, is now free from the disease.
Jennifer Robertson was diagnosed with gastro-oesophageal cancer in 2024, and was chosen to take part in the groundbreaking treatment.
The breakthrough treatment sees the vaccine built for the patient’s own immune system, aiming to optimise its efficiency in targeting cancerous cells.
Follow STV News on WhatsApp
Scan the QR code on your mobile device for all the latest news from around the country
